OLDAKER & WILLISON, LLP for JUUL LABS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 16, 2021 | $48,000 | Replaced |
| 1st Quarter - Amendment | Apr 19, 2021 | $48,000 | Replaced |
| 1st Quarter - Amendment | Apr 22, 2021 | $36,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade; H.R. ____/S____,Labor,Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases. S. 2517, Tobacco Tax Equity Act of 2019; S. 2519, Prohibiting Non-tobacco E-cigarette Flavors; S. 2536, E-Cigarette Device Standards Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW B. WILLISON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.